The type I interferon system in the etiopathogenesis of auto(9)

236L.Rönnblom

51.PisetskyDS,RönnblomL.Systemiclupuserythematosus:

amatteroflifeanddeath.ArthritisRheum.2009;60:1567–ndeR,GangulyD,FacchinettiV,FrascaL,ConradC,

GregorioJ,etal.Neutrophilsactivateplasmacytoiddendriticcellsbyreleasingself-DNA-peptidecomplexesinsystemiclupuserythematosus.SciTranslMed.2011;3:73ra19.

53.Garcia-RomoGS,CaielliS,VegaB,ConnollyJ,AllantazF,

XuZ,tingneutrophilsaremajorinducersoftypeIIFNproductioninpediatricsystemiclupuserythematosus.SciTranslMed.2011;3:73ra20.

54.LoodC,GullstrandB,TruedssonL,OlinAI,AlmGV,

RönnblomL,etal.C1qinhibitsimmunecomplex-inducedinterferon-aproductioninplasmacytoiddendriticcells:anovellinkbetweenC1qde ciencyandsystemiclupuserythematosuspathogenesis.ArthritisRheum.2009;60:3081–90.

55.SanterDM,HallBE,GeorgeTC,TangsombatvisitS,

LiuCL,ArkwrightPD,etal.C1qde ciencyleadstothedefectivesuppressionofIFN-ainresponsetonucleoproteincontainingimmunecomplexes.JImmunol.2010;185:4738–49.

56.WalportMJ,DaviesKA,BottoM.C1qandsystemiclupus

erythematosus.Immunobiology.1998;199:265–85.

57.VollmerJ,TlukS,SchmitzC,HammS,JurkM,

ForsbachA,etal.Immunestimulationmediatedbyautoanti-genbindingsiteswithinsmallnuclearRNAsinvolvesToll-likereceptors7and8.JExpMed.2005;202:1575–85.

58.LövgrenT,ElorantaML,KastnerB,Wahren-HerleniusM,

.

y

lAlmGV,RönnblomL.Inductionofinterferon-abyimmuneno complexesorliposomescontainingsystemiclupuserythema-esutosusautoantigen-andSjögren’ssyndromeautoantigen-l anassociatedRNA.ArthritisRheum.2006;54:1917–27.

os59.HuaJ,KirouK,LeeC,CrowMK.FunctionalassayoftypeI

repinterferoninsystemiclupuserythematosusplasmaandasso- rFociationwithanti-RNAbindingproteinautoantibodies.Arthri-tisRheum.2006;54:1906–16.

60.ArbuckleMR,McClainMT,RubertoneMV,Sco eldRH,

DennisGJ,JamesJA,etal.Developmentofautoantibodiesbeforetheclinicalonsetofsystemiclupuserythematosus.NEnglJMed.2003;349:1526–33.

61.McClainMT,HeinlenLD,DennisGJ,RoebuckJ,HarleyJB,

JamesJA.Earlyeventsinlupushumoralautoimmunitysug-gestinitiationthroughmolecularmimicry.NatMed.2005;11:85–9.

62.ElorantaML,Franck-LarssonK,LovgrenT,KalamajskiS,

RönnblomA,RubinK,etal.TypeIinterferonsystemactivationandassociationwithdiseasemanifestationsinsys-temicsclerosis.AnnRheumDis.2010;69:1396–402.

63.ElorantaML,LövgrenT,FinkeD,MathssonL,RönnelidJ,

KastnerB,etal.Regulationoftheinterferon-aproduc-tioninducedbyRNA-containingimmunecomplexesinplasmacytoiddendriticcells.ArthritisRheum.2009;60:2418–27.

64.HagbergN,BerggrenO,LeonardD,WeberG,BrycesonYT,

AlmGV,etal.IFN-aproductionbyplasmacytoiddendriticcellsstimulatedwithRNA-containingimmunecomplexesispromotedbyNKcellsviaMIP-1bandLFA-1.JImmunol.2011;186:5085–94.

65.IzaguirreA,BarnesBJ,AmruteS,YeowWS,MegjugoracN,

DaiJ,parativeanalysisofIRFandIFN-alphaexpressioninhumanplasmacytoidandmonocyte-deriveddendriticcells.JLeukocBiol.2003;74:1125–38.

66.SigurdssonS,NordmarkG,GöringHH,LindroosK,

WimanAC,SturfeltG,etal.Polymorphismsinthetyrosinekinase2andinterferonregulatoryfactor5genesareassociated

withsystemiclupuserythematosus.AmJHumGen.2005;76:528–37.

67.

SigurdssonS,PadyukovL,KurreemanFAS,LiljedahlU,WimanA-C,AlfredssonL,etal.Associationofahaplotypeinthepromotorregionoftheinterferonregulatoryfactor5genewithrheumatoidarthritis.ArthritisRheum.2007;56:2202–10.

68.

NordmarkG,KristjansdottirG,TheanderE,ErikssonP,BrunJG,WangC,etal.AdditiveeffectsofthemajorriskallelesofIRF5andSTAT4inprimarySjogren’ssyndrome.GenesImmun.2009;10:68–76.

69.

SigurdssonS,GöringHH,KristjansdottirG,MilaniL,NordmarkG,SandlingJ,prehensiveevaluationofthegeneticvariantsofinterferonregulatoryfactor5revealsanovel5bplengthpolymorphismasstrongriskfactorforsystemiclupuserythematosus.HumMolGenet.2008;17:872–81.

70.

FengD,StoneRC,ElorantaML,Sangster-GuityN,NordmarkG,SigurdssonS,etal.Geneticvariantsanddisease-associatedfactorscontributetoenhancedinterferonregulatoryfactor5expressioninbloodcellsofpatientswithsystemiclupuserythematosus.ArthritisRheum.2010;62:562–73.

71.

NiewoldTB,KellyJA,FleschMH,EspinozaLR,HarleyJB,CrowMK.AssociationoftheIRF5riskhaplotypewithhighseruminterferon-aactivityinsystemiclupuserythematosuspatients.ArthritisRheum.2008;58:2481–7.

72.

SandlingJK,GarnierS,SigurdssonS,WangC,NordmarkG,GunnarssonI,etal.AcandidategenestudyofthetypeIinterferonpathwayimplicatesIKBKEandIL8asrisklociforSLE.EurJHumGenet.2011;19:479–84.

73.

TylerDR,PerskyME,MatthewsLA,ChanS,FarrarJD.Pre-assemblyofSTAT4withthehumanIFN-a/b?receptor-2subunitismediatedbytheSTAT4N-domain.MolImmu-nol.2007;44:1864–72.

74.

RemmersEF,PlengeRM,LeeAT,GrahamRR,HomG,BehrensTW,etal.STAT4andtheriskofrheumatoidarthritisandsystemiclupuserythematosus.NEnglJMed.2007;357:977–86.

75.

TaylorKE,RemmersEF,LeeAT,OrtmannWA,PlengeRM,TianC,etal.Speci cityoftheSTAT4geneticassociationforseverediseasemanifestationsofsystemiclupuserythematosus.PLoSGenet.2008;4:e1000084.

76.

SigurdssonS,NordmarkG,GarnierS,GrundbergE,KwanT,NilssonO,etal.AriskhaplotypeofSTAT4forsystemiclupuserythematosusisover-expressed,correlateswithanti-dsDNAandshowsadditiveeffectswithtworiskallelesofIRF5.HumMolGenet.2008;17:2868–76.

77.

CunninghameGrahamDS,AkilM,VyseTJ.Associationofpolymorphismsacrossthetyrosinekinasegene,TYK2inUKSLEfamilies.Rheumatology(Oxford).2007;46:927–30.78.

MoserKL,KellyJA,LessardCJ,HarleyJB.Recentinsightsintothegeneticbasisofsystemiclupuserythematosus.GenesImmun.2009;10:373–9.

79.

FuQ,ChenX,CuiH,GuoY,ChenJ,ShenN,etal.Associationofelevatedtranscriptlevelsofinterferon-induciblechemokineswithdiseaseactivityandorgandamageinsys-temiclupuserythematosuspatients.ArthritisResTher.2008;10:R112.

80.

ShiozawaS,KurokiY,KimM,HirohataS …… 此处隐藏：3741字，全部文档内容请下载后查看。喜欢就下载吧 ……